arrow
M

Maria Grazia Castagna

university of siena
H指数:35
被引数:5,868

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Network based approach identifies miR-145-3p as a central regulatory hub associated to the progression from localized to metastatic medullary thyroid carcinoma

网络分析方法鉴定出miR-145-3p是从局部到转移性甲状腺髓样癌进展中的核心调控中心

2026-09-090
OAAI
Determinants of Health-Related Quality of Life in Differentiated and Poorly Differentiated Thyroid Cancer Patients With Structural Incomplete Response: A Multicenter Cross-Sectional Study

分化型和低分化甲状腺癌结构不完全应答患者的健康相关生活质量影响因素:一项多中心横断面研究

2026-04-020
OAAI
Sex Hormone Profiles in Patients With Torsades de Pointes Ventricular Tachycardia

扭转性室性心动过速患者中的性激素谱

2025-08-280
OAAI
Clinical and Pathological Factors Associated with Disease Persistence in Pediatric Patients with Differentiated Thyroid Carcinoma

分化型甲状腺癌患儿疾病持续存在的临床及病理相关因素

Thyroid
IF6.7
2025-07-300
PRE
Data-driven Thyroglobulin Cutoffs for Low- and Intermediate-risk Thyroid Cancer Follow-up: ITCO Real-world Analysis
2024-08-161
OA
Circulating cell-free DNA (cfDNA) in patients with medullary thyroid carcinoma is characterized by specific fragmentation and methylation changes with diagnostic value

甲状腺髓样癌患者循环游离DNA (cfDNA) 以特异性片段化和甲基化改变为特征具有诊断价值

2023-09-191
OAAI
Circulating miR-26b-5p and miR-451a as diagnostic biomarkers in medullary thyroid carcinoma patients (Jun, 10.1007/s40618-023-02115-2, 2023)
2023-08-100
OAAI
Circulating miR-26b-5p and miR-451a as diagnostic biomarkers in medullary thyroid carcinoma patients
2023-06-077
OAAI
A Data-Driven Approach to Refine Predictions of Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter Study
2023-02-1614
PRE